Sentence examples for efficacy targeting from inspiring English sources

The introduction of novel technologies has the potential to support the development of vaccines with increased efficacy targeting infections as well as non-communicable diseases.

Based on the fact that in all three conditions tested, there was no significant change in the diameter of the nanoliposome, it is considered that the nanoliposomes prepared in our study have the physical stability in PBS (pH 7.4) for at least 3 weeks without aggregation or flocculation, which can affect therapeutic efficacy, targeting, and toxicity of the drug(s) encapsulated in the nanoliposomes.

The recombinant adenovirus presented in this work showed potent antitumor efficacy targeting AFP-positive HCC.

Clinical consensus on FXS appears to hold that SSRIs may be better tolerated in persons with FXS compared with youth with idiopathic ASD, where SSRI controlled trials have noted significant adverse effect rates and a lack of efficacy targeting repetitive behavior.

Studies have found potential evidence of efficacy targeting epidermal growth factor receptor (EGFR) in combination with endocrine therapy [ 1], and insulin-like growth factor 1 receptor in combination with mammalian target of rapamycin inhibitors [ 2], although none of these approaches have as yet proceeded beyond phase II trials.

Also, multi-functionalized nanostructures are characterized by enhanced bioavailability, efficacy, targeted localization, active cellular uptake, and low side effects.

Due to their fantastic efficacy, targeted cancer therapies have been accepted as a great success in treating many types of cancer [2].

These features open the door not only to identifying a cancer genetic signature for diagnosis but also to developing many alternative therapies for cancer that could enhance treatment efficacy, targeted therapies in particular.

All trough concentration patients were superior to the efficacy target (2 mg/L).

An achievable efficacy target needs to be set while standardisation of trial outcomes and critical choices based on the vaccine development pipeline need to be made.

This outcome depends more on manufacturers' ability to produce LEDs that follow DOE's lamp production cost and efficacy targets, than on reducing power electronics costs for DC building circuits and voltage standardization.